Clinical trial
Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients…
NCT00145652 · Sundsvall Hospital, Other · Completed
Key facts
| NCT number | NCT00145652 |
|---|---|
| Title | Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. |
| Official title | Phase 3 Study of Recombinant Erythropoetin and Adjuvant I.V. Iron Therapy of Anemic Patients With Lymphoproliferative Disorders |
| Lead sponsor | Sundsvall Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Multiple Myeloma, Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | Neo-Recormon and Venofer |
| Enrollment | 66 |
| Start date | Dec 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Sep 5, 2005 |
| Last update posted | Jul 30, 2007 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: